Aspire-Lakewood Holdings, Inc. SEC filings ASBPW

Aspire-Lakewood Holdings, Inc. has 228 filings in SEC EDGAR's recent list, going back to Mar 16, 2021. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (auditor change). The company's fiscal year ends on December 31.

Form Description Filed Period
DEF 14A Proxy statement May 8, 2026 May 8, 2026
PRE 14A Preliminary proxy statement Apr 27, 2026 Apr 27, 2026
DEF 14A Proxy statement Feb 24, 2026 Feb 24, 2026
PRE 14A Preliminary proxy statement Feb 12, 2026 Feb 12, 2026
DEF 14A Proxy statement Sep 23, 2025 Sep 22, 2025
PRE 14A Preliminary proxy statement Sep 8, 2025 Sep 8, 2025
DEF 14A Proxy statement May 1, 2024 May 1, 2024
PRE 14A Preliminary proxy statement Apr 18, 2024 Apr 18, 2024
DEFA14A Additional proxy material May 1, 2023 —
DEF 14A Proxy statement Apr 21, 2023 May 18, 2023
PRE 14A Preliminary proxy statement Apr 5, 2023 Apr 5, 2023

Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ASBP (Nasdaq), ASBPW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Cayman Islands
Headquarters
Estero, FL
SEC filer status
, Emerging growth company
SEC CIK
1847345
Former names
Aspire Biopharma Holdings, Inc. (until Sep 9, 2026); PowerUp Acquisition Corp. (until Feb 19, 2025)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.